Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olive oil is a complex dietary lipid mixture extracted from the fruit of the Olea europaea tree (Wikipedia, 2024). It is primarily composed of triglycerides, with oleic acid being the most abundant fatty acid, alongside bioactive minor constituents such as polyphenols like oleocanthal and hydroxytyrosol (PubMed, PMID: 30308973). Olive oil is not a therapeutic target; rather, it is a substance containing multiple compounds that interact with various biological targets, including cyclooxygenase (COX) enzymes and peroxisome proliferator-activated receptors (PPARs) (NIH, 2023). Its consumption is strongly associated with cardiovascular health, primarily through the improvement of lipid profiles and the reduction of oxidative stress and systemic inflammation (StatPearls, 2023). In pharmaceutical science, olive oil is frequently utilized as an excipient or a solvent for lipophilic drug formulations (PubChem, 2024). The phenolic component oleocanthal has been specifically noted for its ibuprofen-like anti-inflammatory properties via non-selective COX inhibition (Nature, 2005). Hydroxytyrosol, another key component, serves as a potent scavenger of reactive oxygen species and a modulator of mitochondrial function (PubMed, PMID: 31035318). Overall, while not a drug or a target, olive oil serves as a critical dietary component with significant pharmacological implications for metabolic and inflammatory diseases.
Olive oil is a complex mixture and not a discrete therapeutic target. Its components, such as oleocanthal, act as natural non-selective inhibitors of cyclooxygenase (COX) enzymes, similar to ibuprofen (Nature, 2005). Other components like hydroxytyrosol act as potent antioxidants and modulators of lipid metabolism via Nrf2 and PPAR-alpha pathways (PubMed, PMID: 31035318).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olive oil.